Q4 sales increased by 24%; Q4 operating margin gained 200bp on a very low comparison basis. FY15 sales increased by 14.4% (8% at CER) and operating profit by only 7.5%. Operating cash flow decreased by c. 10% to 5.5% of sales.
02 Feb 2016
Strong Q4 on a low comparison basis
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong Q4 on a low comparison basis
Carl Zeiss Meditec AG (AFX:WBO) | 0 0 1.8% | Mkt Cap: 4,494m
- Published:
02 Feb 2016 -
Author:
Armelle Moulin -
Pages:
2
Q4 sales increased by 24%; Q4 operating margin gained 200bp on a very low comparison basis. FY15 sales increased by 14.4% (8% at CER) and operating profit by only 7.5%. Operating cash flow decreased by c. 10% to 5.5% of sales.